Results 131 to 140 of about 1,141,201 (199)

Distinct clinical clusters of paediatric patients with status epilepticus: Retrospective cohort study

Developmental Medicine &Child Neurology, Volume 68, Issue 9, Page 1305-1315, September 2026.
Large Swiss cohort of paediatric status epilepticus demonstrates that treatment delay (> 60 min) directly contributes to morbidity. Machine‐learning analysis of routine clinical data identifies three distinct patient clusters: febrile status epilepticus, severe para‐infectious status epilepticus, and status epilepticus in children with known epilepsy ...
Richard J Burman, Anne Steinberg, Jamie Norris, Giorgio Selmin, Tommaso Fedele, Richard E Rosch, Georgia Ramantani   +6 more
wiley   +1 more source

Baseline Dynamics and Sleep Loss–Driven Changes of Electrocorticographic Aperiodic Properties Are Altered in Mice Lacking Neuroligin‐2

European Journal of Neuroscience, Volume 64, Issue 6, September 2026.
The current study used a wavelet‐leaders formalism to explore the role of Neuroligin‐2, a key protein of gamma‐aminobutyric acid (GABA)‐ergic synapses, in modulating the spectral power decay of electrocorticographic activity during wake and sleep states.
Tanya Leduc, Janine El Helou, Erika Bélanger‐Nelson, Clément Bourguignon, Jean‐Marc Lina, Valérie Mongrain   +5 more
wiley   +1 more source

Safety of synthetic cannabidiol as a novel food pursuant to regulation (EU) 2015/2283

EFSA Journal, Volume 24, Issue 9, September 2026.
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on cannabidiol (CBD) obtained by chemical synthesis as a novel food (NF) pursuant to Regulation (EU) 2015/2283.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Dominique Turck, Torsten Bohn, Montaña Cámara, Jacqueline Castenmiller, Stefaan De Henauw, Ángeles Jos, Alexandre Maciuk, Inge Mangelsdorf, Breige McNulty, Androniki Naska, Kristina Pentieva, Alfonso Siani, Frank Thies, Francesco Cubadda, Harry J. McArdle, Viviana Trezza, Océane Albert, Elisa Beneventi, Marcello Laganaro, Irene Nuin Garciarena, Annamaria Rossi, Sebastián Berrío Cruz, Francesca Seminati, Maura Magani, Karen Ildico Hirsch‐Ernst   +26 more
wiley   +1 more source

Advancing Disease Modification in Dravet Syndrome. [PDF]

Epilepsy Curr
Fine AL.
europepmc   +1 more source

Safety of cannabidiol isolated from Cannabis sativa L. as a novel food pursuant to Regulation (EU) 2015/2283

EFSA Journal, Volume 24, Issue 9, September 2026.
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on cannabidiol (CBD) isolated from Cannabis sativa L. as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF consists of ≥ 98% w/w CBD.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Dominique Turck, Torsten Bohn, Montaña Cámara, Jacqueline Castenmiller, Stefaan De Henauw, Ángeles Jos, Alexandre Maciuk, Inge Mangelsdorf, Breige McNulty, Androniki Naska, Kristina Pentieva, Alfonso Siani, Frank Thies, Francesco Cubadda, Harry J. McArdle, Viviana Trezza, Océane Albert, Elisa Beneventi, Marcello Laganaro, Irene Nuin Garciarena, Annamaria Rossi, Sebastián Berrío Cruz, Francesca Seminati, Maura Magani, Karen Ildico Hirsch‐Ernst   +26 more
wiley   +1 more source

Hippocampal malformation in Dravet syndrome. [PDF]

Epilepsia
Okutoyi NE, Maru V, Nauen DW.
europepmc   +1 more source

Antisense oligonucleotides modulate aberrant inclusion of poison exons in SCN1A-related Dravet syndrome

JCI Insight
Dravet syndrome is a developmental and epileptic encephalopathy associated with pathogenic variants in SCN1A. Most disease-causing variants are located within coding regions, but recent work has shed light on the role of noncoding variants associated ...
Sheng Tang, Hannah Stamberger, Jeffrey D. Calhoun, Sarah Weckhuysen, Gemma L. Carvill   +4 more
doaj   +1 more source

Safety of Cannabis sativa L. extract as a novel food pursuant to Regulation (EU) 2015/2283

EFSA Journal, Volume 24, Issue 9, September 2026.
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on Cannabis sativa L. extract as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF consists of 57%–65% w/w cannabidiol (CBD) and 9%–17% w/w of other cannabinoids.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Dominique Turck, Torsten Bohn, Montaña Cámara, Jacqueline Castenmiller, Stefaan De Henauw, Ángeles Jos, Alexandre Maciuk, Inge Mangelsdorf, Breige McNulty, Androniki Naska, Kristina Pentieva, Alfonso Siani, Frank Thies, Francesco Cubadda, Harry J. McArdle, Viviana Trezza, Océane Albert, Elisa Beneventi, Marcello Laganaro, Irene Nuin Garciarena, Annamaria Rossi, Sebastián Berrío Cruz, Francesca Seminati, Maura Magani, Karen Ildico Hirsch‐Ernst   +26 more
wiley   +1 more source

Augmenting and Assaying Nav1.1 Protein Quantity for Dravet Syndrome Therapy. [PDF]

Ann Clin Transl Neurol
Saravanan A, Safran J, Loughman A, Lin G, Vaid S, Allababidi D, Tessier PM, Dang LT.   +7 more
europepmc   +1 more source

Lost in Sleep Transition: Tangled Sleep and Thermoregulation in Dravet Syndrome. [PDF]

Epilepsy Curr
Wong JC.
europepmc   +1 more source